MTEMQ

NASDAQ:MTEMQ USA Biotechnology
Market Cap
$0.94
Market Cap Rank
#51433 Global
#16114 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.03
All Time High
$0.03
About

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies through its proprietary biologic drug platform technology (ETB). It is also developing MT- 8421, an ETB candidate that is in Phase I clinical trial for th… Read more

MTEMQ (MTEMQ) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of June 2024: -0.824x

Based on the latest financial reports, MTEMQ (MTEMQ) has a cash flow conversion efficiency ratio of -0.824x as of June 2024.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.86 Million) by net assets ($7.11 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

MTEMQ - Cash Flow Conversion Efficiency Trend (2020–2023)

This chart illustrates how MTEMQ's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

MTEMQ Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of MTEMQ ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for MTEMQ (2020–2023)

The table below shows the annual cash flow conversion efficiency of MTEMQ from 2020 to 2023.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2023-12-31 $4.21 Million $-41.82 Million -9.929x -268.77%
2022-12-31 $-15.13 Million $-89.02 Million 5.883x +1371.27%
2021-12-31 $65.66 Million $-30.39 Million -0.463x +67.23%
2020-12-31 $59.34 Million $-83.80 Million -1.412x --